Feeds › Insider trades
Insider trades
Open-market buys and sells by officers, directors and 10% owners, from SEC Form 4. Usually filed within two business days.
About this data
- What it is
- When a company's officers, directors or owners of more than 10% buy or sell its stock, they must report the trade to the SEC on Form 4. This feed shows purchases and sales on the open market; stock grants, option exercises and shares withheld for tax are left out.
- Who files it
- The insider, usually through the company, within two business days of the trade.
- How current
- We collect new filings throughout the day on SEC business days.
- Worth knowing
- Sales are often routine: insiders sell to diversify, to pay taxes, or under a 10b5-1 plan set up months in advance. A purchase with their own money is less common, which is why many investors pay closer attention to it.
All of this comes from public filings.
Source and freshness · Information, not investment advice (disclaimer).
Open-market trades per day, last 30 days
Purchases Sales
By trade date. Insiders have two business days to file, so the most recent days fill in later.
Latest open-market insider trades
Showing: ticker IBRX
| Traded | Insider | Company | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| Jul 2, 2026 | Cheryl Cohen Director | IBRX ImmunityBio, Inc. | Sale | 131,210 | $9.50 | $1.2M Sale | Form 4 ↗ |
| Jul 1, 2026 | Christobel Selecky Director | IBRX ImmunityBio, Inc. | Sale | 159,478 | $9.02 | $1.4M Sale | Form 4 ↗ |
| Jun 30, 2026 | Christobel Selecky Director | IBRX ImmunityBio, Inc. | Sale | 1,000 | $9.00 | $9,000 Sale | Form 4 ↗ |
| Jun 29, 2026 | Christobel Selecky Director | IBRX ImmunityBio, Inc. | Sale | 95,722 | $9.01 | $862.5K Sale | Form 4 ↗ |
| Jun 24, 2026 | Barry J. Simon Director | IBRX ImmunityBio, Inc. | Sale | 25,000 | $7.88 | $197.0K Sale | Form 4 ↗ |
| Jun 4, 2026 | Barry J. Simon Director | IBRX ImmunityBio, Inc. | Sale | 23,033 | $7.18 | $165.4K Sale | Form 4 ↗ |
| Feb 24, 2026 | Barry J. Simon Director | IBRX ImmunityBio, Inc. | Sale | 75,000 | $12.01 | $900.8K Sale | Form 4 ↗ |
| Feb 23, 2026 | Christobel Selecky Director | IBRX ImmunityBio, Inc. | Sale | 25,000 | $10.00 | $250.0K Sale | Form 4 ↗ |
| Feb 23, 2026 | Barry J. Simon Director | IBRX ImmunityBio, Inc. | Sale | 165,000 | $10.25 | $1.7M Sale | Form 4 ↗ |
| Feb 20, 2026 | Barry J. Simon Director | IBRX ImmunityBio, Inc. | Sale | 10,000 | $9.25 | $92.5K Sale | Form 4 ↗ |
| Jan 20, 2026 | Christobel Selecky Director | IBRX ImmunityBio, Inc. | Sale | 25,000 | $7.51 | $187.8K Sale | Form 4 ↗ |
| Jan 20, 2026 | Barry J. Simon Director | IBRX ImmunityBio, Inc. | Sale | 75,000 | $7.88 | $591.0K Sale | Form 4 ↗ |
| Jan 20, 2026 | Barry J. Simon Director | IBRX ImmunityBio, Inc. | Sale | 76,967 | $6.54 | $503.4K Sale | Form 4 ↗ |
| Jan 16, 2026 | Christobel Selecky Director | IBRX ImmunityBio, Inc. | Sale | 50,000 | $5.00 | $250.0K Sale | Form 4 ↗ |
14 items, most recent first (up to 50). Every row links to its original filing. Updated Nov 15, 2026, 5:40 PM EST.
Download CSV The rows of this feed, with the filters above. A download holds at most 10,000 rows; narrow the filters to get a smaller slice.
Other feeds: Congressional trades · Executive-branch trades · Bills in Congress · Roll-call votes · Corporate PAC donations · Lobbying · Capitol Hires · Lobbying and contracts · Government contracts · Planned insider sales · Executive pay · Ownership stakes (13D / 13G) · Institutional holdings (13F) · Short interest · Fails to deliver · Daily short volume · Wikipedia page views · App store ratings · H-1B visa applications · Stock splits · 8-K events · IPO filings · Deals · Private placements (Form D) · Merger clearances (HSR) · Layoff notices (WARN) · SEC enforcement · Patents · Clinical trial updates · FDA approvals and clearances